Global Active Pharmaceutical Ingredients Market 2011-2015

TechNavio's analysts forecast the Global Active Pharmaceutical Ingredient market to grow at a CAGR of 7.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the entry of novel formulation technologies. The Global Active Pharmaceutical Ingredient market has also been witnessing the trend of increasing outsourcing of API manufacturing to China and India. However, the stringent regulatory environment could pose a challenge to the growth of this market.

TechNavio's report, the Global Active Pharmaceutical Ingredient Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Active Pharmaceutical Ingredient market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Lonza Group Ltd., Boehringer Ingelheim GmbH, Royal DSM N.V. and BASF SE.

Other vendors mentioned in the report are Bayer AG, Merck & Co., Mylan Inc., Hospira Inc., GlaxoSmithKline plc, Pfizer Inc., Eli Lilly and Co., Sanofi S.A., Zhejiang Hisun Pharmaceutical Co. Ltd., Ranbaxy Laboratories Ltd., Dr. Reddy's Laboratories Ltd., Watson Pharmaceuticals Inc. and Teva Pharmaceuticals Industries Ltd.

Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.

01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Product Offerings
04. Market Landscape
04.1 Global Active Pharmaceutical Ingredients Market
Market Size and Forecast
Market Segmentation
Market Share of Market Segments by Type of Synthesis
Forecast of Market Share of Market Segments by Type of Synthesis
Sub-segmentation of Biotech API Segment
04.2 Global Biotech Active Pharmaceutical Ingredients Market
Market Size and Forecast
04.3 Global Synthetic Active Pharmaceutical Ingredients Market
Market Size and Forecast
04.4 Global High Potency Active Pharmaceutical Ingredients Market
Market Size and Forecast
Global High Potency Active Pharmaceutical Ingredients Market Segmentation Based on Type of Synthesis
Global High Potency Active Pharmaceutical Ingredients Market Segmentation Based on Customer Base
04.5 Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
USA
Japan
China
Economic Indicators of Key Leading Countries
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Lonza Group Ltd.
Business Overview
SWOT Analysis
14.2 Boehringer Ingelheim GmbH
Business Overview
SWOT Analysis
14.3 Royal DSM N.V.
Business Overview
SWOT Analysis
14.4 BASF SE
Business Overview
SWOT Analysis
15. Other Reports in this Series

List of Exhibits:
Exhibit 1: Global Active Pharmaceutical Ingredients Market 2011-2015 (US$ billion)
Exhibit 2: Market Segmentation by Type of Synthesis
Exhibit 3: Market Segmentation by Type of Technology
Exhibit 4: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Synthesis 2011
Exhibit 5: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Synthesis 2011-2015 (percentage)
Exhibit 6: Biotech Active Pharmaceutical Ingredients Segment Sub-segmentation 2011
Exhibit 7: Global Biotech Active Pharmaceutical Ingredients Market 2011-2015 (US$ billion)
Exhibit 8: Global Synthetic Active Pharmaceutical Ingredients Market 2011-2015 (US$ billion)
Exhibit 9: Global High Potency Active Pharmaceutical Ingredients Market 2011-2015 (US$ billion)
Exhibit 10: Global High Potency Active Pharmaceutical Ingredients Market Segmentation Based on Type of Synthesis
Exhibit 11: Global High Potency Active Pharmaceutical Ingredients Market Segmentation by Type of Synthesis 2011
Exhibit 12: Global High Potency Active Pharmaceutical Ingredients Market Segmentation Based on Customer Base
Exhibit 13: Global High Potency Active Pharmaceutical Ingredients Market Segmentation by Customer Base 2011
Exhibit 14: Global Active Pharmaceutical Ingredients Market by Geographical Segmentation 2011